Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy

NCT00280059 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

660

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy, Partial

Interventions

DRUG: Pregabalin
DRUG: Lamotrigine

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.